Abstract
Background and aim
Objectives are to explore recent advances in discovery of new antidiabetic agents using repurposing strategies and to discuss modern technologies used for drug repurposing highlighting diabetic specific web portal.
Methods
Recent literature were studied and analyzed from various sources such as Scopus, PubMed, and IEEE Xplore databases.
Results
Drugs like Niclosamideethanolamine, Methazolamide, Diacerein, Berberine, Clobetasol, etc. with possibility of repurposing to curb diabetes can be potential late-stage clinical candidates, providing access to information on pharmacology, formulation, and probable toxicity if any.
Conclusions
With collaboration of artificial intelligence (AI) with pharmacology, the efficiency of drug repurposing can improve significantly.
【저자키워드】 Drug repurposing, artificial intelligence, diabetes, Modern computational intelligence models, Molecular property diagnostic suite diabetes mellitus (MPDSDM), 【초록키워드】 Toxicity, drug, information, Efficiency, berberine, methazolamide, Diabetic, Candidates, recent, objective, IMPROVE, Result, analyzed, significantly, diabete, highlighting, Clobetasol, Diacerein, 【제목키워드】 Epidemic, diabete,